Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, April 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Evaporation Chemistry at ACS
Monday, August 19, 2013
Genevac to display its latest products for productive evaporation in USA.

Huber Presents the 4 Aces of Temperature Control!
Thursday, August 15, 2013
Huber has a winning hand with a suite of very compact, high efficiency and low-cost products.

Thermo Fisher Scientific Expands Water Purification Portfolio
Thursday, August 01, 2013
Advanced dispensing technology increases flexibility and ease-of-use for shared lab environments.

Thermo Fisher Scientific Showcases New Small Benchtop Centrifuge at AACC
Thursday, August 01, 2013
Provides scientists with outstanding capacity in a compact design.

ChanTest Announces ChansPorter™ Assays to Accelerate Drug Development
Monday, July 22, 2013
ChansPorter™ Assays provide the best means possible for measuring the functional activity of important pharmaceutical targets, including the Cystic Fibrosis Transmembrane conductance Regulator (CFTR).

Evaluate Launches Enhanced Orphan Drug Intelligence
Monday, July 15, 2013
Available to EvaluatePharma® service clients beginning June 20, 2013.

ThromboGenics’ JETREA® Launched in Denmark and Sweden
Monday, July 08, 2013
Roll out in Finland and Norway to follow shortly.

Cresset Seeks Partners for Beta Testing of Groundbreaking New Activity Miner Module for Rapid 3D SAR Interpretation
Tuesday, July 02, 2013
At Field Based Chemistry Europe, Dr Tim Cheeseright presented a pre-release of Cresset’s new Activity Miner module.

CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
Tuesday, June 25, 2013
Company introduces Liberty Blue™ and Liberty XL™ microwave peptide synthesizer.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 1235
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv